The regulatory file for walnut protein peptides
A walnut protein peptide file has to answer four questions: what the material is, which lot is being released, whether the destination allows the ingredient, and what the label must say about the tree nut. The buyer's regulatory team confirms the route for the destination; this page sets out the documents and the allergen logic that review depends on. No novel-food, NDI or permitted-ingredient status is asserted here.
Walnut is both the source and the allergen: the label has to name it, the lot file has to carry the statement, and the buyer's team has to confirm the route for the destination.
What the file has to answer
The file has four jobs. It identifies the material and the specification revision; it ties the release to a lot and a certificate; it sets out the route, limits and label for the destination; and it records what happens when the source, process or pack changes. The certificate, the technical data sheet and the safety data sheet each answer part of that, and none answers the route on its own.
Walnut adds one document that a generic protein file may not have: a tree-nut allergen statement that names both the source and the class. “Tree nut” without walnut is incomplete, and “walnut” without the class can be missed by a reader scanning for the class. The statement belongs in the controlled document set, with a version, not only on the certificate.
Other markets maintain their own lists. Canada includes walnut among tree nuts, and Australia and New Zealand require tree-nut declarations under the Food Standards Code. The current text of each destination is the reference, and the buyer's team keeps the evidence with the order.
European Union
Regulation (EU) No 1169/2011 Annex II lists walnuts under nuts, so a walnut peptide must be declared in the ingredient list and emphasised by typography. There is no threshold below which the declaration can be dropped, and the fact that the protein has been hydrolysed does not create an exemption. The declaration follows the source.
The first EU question is novel food. Regulation (EU) 2015/2283 covers food that was not used for human consumption to a significant degree in the Union before 15 May 1997. Whether a particular walnut hydrolysate falls inside that definition depends on its history and its process, so the buyer's team checks the novel food catalogue and the evidence for the exact material. No status is asserted here.
The rest of the file draws on Regulation (EC) No 1924/2006 for claims, Commission Regulation (EU) 2023/915 for contaminants and the food-information rules for labelling. Great Britain has its own retained rules, and Northern Ireland follows the EU list; the buyer confirms which applies and keeps the evidence with the order. Verify the current text, because these instruments are amended.
United States
In the US, tree nuts are a major food allergen under FALCPA, and walnut is a tree nut. The label must name the source in plain language, either in the ingredient list or in a “Contains” statement. The refined-oil exemption in the statute does not reach a protein hydrolysate: it is written for highly refined oils, not for a peptide powder, and a supplier who invokes it for this material has not shown the basis.
Start with the intended use and the basis for the ingredient. A dietary supplement ingredient is assessed under the Federal Food, Drug, and Cosmetic Act as amended by DSHEA. If it is a new dietary ingredient, the 21 CFR 190.6 notification is due at least 75 days before marketing; the buyer's team decides whether that applies. 21 CFR 111 covers cGMP and 21 CFR 101 covers labelling.
Contaminants and limits
The contaminant calculation belongs to the finished product, not to the drum. The destination text and the daily dose set the limit; the table below is the list of questions to ask, not a set of universal numbers.
| Parameter | Why it belongs in a walnut file | What the file should show |
|---|---|---|
| Lead (Pb) | A general supplement contaminant | Lot result, method, limit and dose calculation |
| Cadmium (Cd) | Nuts can accumulate it | Lot result and any category exception |
| Mercury (Hg) | A general supplement contaminant | Lot result and method |
| Arsenic (As) | A market or customer limit | The agreed limit and method |
| Aflatoxin | Tree nuts can carry it | A risk-based panel and the destination limit |
| Microbiology | Powder handling and water activity | Counts and absence tests |
Aflatoxin is the walnut-specific item that a generic certificate may not cover. The catalog specification here does not list it, so the buyer should ask whether the source monitors it and whether the lot can be tested against the destination limits. Pesticides and residual solvents are separately agreed.
Claims and the label
No disease claim is made for this ingredient. In the EU, a protein claim is calculated on the finished product: “source of protein” needs at least 12% of the energy value from protein, and “high protein” needs at least 20%. In the US, “good source” is 10% or more of the daily value per reference amount, and “excellent source” or “high” is 20% or more. “Peptide” describes a fraction; it is not an authorised health claim, and the figure behind it must be on the specification if the label uses the word.
The allergen wording is not a marketing choice. A walnut peptide cannot carry a “tree-nut-free” claim, and a “walnut-free” claim would be false. A “may contain” statement needs a cross-contact assessment and cleaning validation behind it; the FDA does not define the phrase, so the wording should follow the control, not habit. The brand's reviewer decides the final label; the certificate does not approve a claim.
The document set
- Specification with the revision number, the walnut source, the nitrogen factor, the peptide window and the mesh.
- Certificate of analysis for the lot, with methods, limits and measured results.
- Technical data sheet and safety data sheet.
- Tree-nut allergen statement naming walnut, with the cross-contact controls for the line.
- Origin record, contaminant results, microbiology and any customer-specific declaration.
- Nutritional data for the protein and peptide figures, with the calculation basis.
- Position on the destination route and the supporting documents the buyer's team needs.
Checklist before the first order
- The specification version, the walnut source and the hydrolysis route are named.
- The novel-food or dietary-ingredient route is confirmed by the buyer's regulatory team for the destination.
- The tree-nut allergen statement names walnut and matches the lot.
- The heavy-metal and aflatoxin results are recalculated for the finished-product dose.
- The label, the nutrition panel and the claim wording have been reviewed for the market.
- Change control covers the source, the process and the pack, and the quotation, specification and certificate refer to the same version.
Catalog values are on the product hub; the lot certificate is explained on the COA page; the source evidence is on the identity page; the framework references are in the EU and US regulatory notes; the release file is described on the quality page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation